Division of Rheumatology, Cedars-Sinai Medical Center, Los Angeles, California 3556, USA.
Ann Rheum Dis. 2013 Mar;72(3):369-73. doi: 10.1136/annrheumdis-2012-201403. Epub 2012 Jul 11.
To estimate the current US inflammatory back pain (IBP) prevalence using four published case definitions.
Analysis of an IBP data collection instrument specifically designed for the 2009-10 National Health and Nutrition Examination Survey. Subjects were 5103 US adults ages 20-69 with complete data. IBP prevalence as determined by Calin et al criteria, European Spondylarthropathy Study Group (ESSG) criteria, and Berlin criteria 8a and 7b.
Age-adjusted US prevalence of IBP by Calin criteria was 5.0% (95% CI 4.2% to 5.8%). Prevalence of IBP was 5.6% (95% CI 4.7% to 6.5%) by ESSG criteria, and 5.8% (95% CI 5.2% to 6.4%) and 6.0% (95% CI 4.9% to 7.1%) by Berlin Criteria 8a and 7b, respectively. IBP prevalence did not differ significantly by age groups or between men and women. IBP prevalence was significantly lower among non-Hispanic black persons compared with non-Hispanic white persons for the Calin and ESSG IBP criteria. For the ESSG and Berlin 7b criteria, non-Hispanic white persons had significantly higher IBP prevalences compared with Mexican Americans.
IBP is associated with spondyloarthritis. Awareness of the prevalence of IBP may be useful for planning future epidemiological studies as well as development and validation of diagnostic and classification criteria for specific clinically defined diseases.
使用四种已发表的病例定义来估计当前美国炎症性背痛(IBP)的流行率。
对专门为 2009-10 年全国健康和营养检查调查设计的 IBP 数据收集工具进行分析。研究对象为 5103 名年龄在 20-69 岁之间、数据完整的美国成年人。根据 Calin 标准、欧洲脊柱关节病研究组(ESSG)标准以及柏林标准 8a 和 7b 确定 IBP 的流行率。
Calin 标准校正年龄后,美国 IBP 的流行率为 5.0%(95%可信区间 4.2%-5.8%)。ESSG 标准的 IBP 流行率为 5.6%(95%可信区间 4.7%-6.5%),柏林标准 8a 和 7b 的 IBP 流行率分别为 5.8%(95%可信区间 5.2%-6.4%)和 6.0%(95%可信区间 4.9%-7.1%)。IBP 的流行率在年龄组之间或男性和女性之间没有显著差异。与非西班牙裔白人相比,Calin 和 ESSG IBP 标准下,非西班牙裔黑人的 IBP 流行率显著较低。对于 ESSG 和柏林 7b 标准,与墨西哥裔美国人相比,非西班牙裔白人的 IBP 流行率显著较高。
IBP 与脊柱关节炎有关。了解 IBP 的流行率可能有助于规划未来的流行病学研究,以及特定临床定义疾病的诊断和分类标准的制定和验证。